27299886|t|Low Soluble Syndecan-1 Precedes Preeclampsia
27299886|a|Syndecan-1 (Sdc1; CD138) is a major transmembrane heparan sulfate proteoglycan expressed on the extracellular, luminal surface of epithelial cells and syncytiotrophoblast, thus comprising a major component of the glycocalyx of these cells. The " soluble " (shed) form of Sdc1 has paracrine and autocrine functions and is normally produced in a regulated fashion. We compared plasma soluble Sdc1 concentrations, in relation to placental Sdc1 expression, in uncomplicated (control) and preeclamptic pregnancies. We evaluated soluble Sdc1 across uncomplicated pregnancy, and between preeclamptic, gestational hypertensive and control patients at mid-pregnancy (20 weeks) and 3rd trimester by ELISA. Placental expression level of Sdc1 was compared between groups in relation to pre-delivery plasma soluble Sdc1. Participants were recruited from Magee-Womens Hospital. In uncomplicated pregnancy, plasma soluble Sdc1 rose significantly in the 1st trimester, and reached an approximate 50-fold increase at term compared to post pregnancy levels. Soluble Sdc1 was lower at mid-pregnancy in women who later developed preeclampsia (P<0.05), but not gestational hypertension, compared to controls, and remained lower at late pregnancy in preeclampsia (P<0.01) compared to controls. Sdc1 was prominently expressed on syncytiotrophoblast of microvilli. Syncytiotrophoblast Sdc1 immunostaining intensities, and mRNA content in villous homogenates, were lower in preeclampsia vs. controls (P<0.05). Soluble Sdc1 and Sdc1 immunostaining scores were inversely associated with systolic blood pressures, and positively correlated with infant birth weight percentile. Soluble Sdc1 is significantly lower before the clinical onset of preeclampsia, with reduced expression of Sdc1 in the delivered placenta, suggesting a role for glycocalyx disturbance in preeclampsia pathophysiology.
27299886	0	3	Low	T080	C0205251
27299886	4	11	Soluble	T080	C1948047
27299886	12	22	Syndecan-1	T116,T123	C1609943
27299886	32	44	Preeclampsia	T046	C0032914
27299886	45	55	Syndecan-1	T116,T123	C1609943
27299886	57	61	Sdc1	T116,T123	C1609943
27299886	63	68	CD138	T116,T123	C1609943
27299886	81	123	transmembrane heparan sulfate proteoglycan	T116,T123	C0062503
27299886	124	133	expressed	T045	C1171362
27299886	141	154	extracellular	T026	C0521119
27299886	156	171	luminal surface	T082	C0205148
27299886	175	191	epithelial cells	T025	C0014597
27299886	196	215	syncytiotrophoblast	T025	C1515108
27299886	258	268	glycocalyx	T026	C0061622
27299886	278	283	cells	T025	C0007634
27299886	291	298	soluble	T080	C1948047
27299886	316	320	Sdc1	T116,T123	C1609943
27299886	325	334	paracrine	T044	C2755743
27299886	339	358	autocrine functions	T044	C2755742
27299886	411	419	compared	T052	C1707455
27299886	420	426	plasma	T031	C0032105
27299886	427	434	soluble	T080	C1948047
27299886	435	439	Sdc1	T116,T123	C1609943
27299886	440	454	concentrations	T081	C1446561
27299886	471	480	placental	T018	C0032043
27299886	481	485	Sdc1	T116,T123	C1609943
27299886	486	496	expression	T045	C1171362
27299886	501	514	uncomplicated	T033	C4314562
27299886	516	523	control	T096	C0009932
27299886	529	541	preeclamptic	T046	C0032914
27299886	542	553	pregnancies	T040	C0032961
27299886	568	575	soluble	T080	C1948047
27299886	576	580	Sdc1	T116,T123	C1609943
27299886	588	611	uncomplicated pregnancy	T033	C4314562
27299886	625	637	preeclamptic	T046	C0032914
27299886	639	663	gestational hypertensive	T047	C0852036
27299886	668	675	control	T096	C0009932
27299886	676	684	patients	T101	C0030705
27299886	688	712	mid-pregnancy (20 weeks)	T079	C0233027
27299886	717	730	3rd trimester	T079	C0032981
27299886	734	739	ELISA	T059	C0014441
27299886	741	750	Placental	T018	C0032043
27299886	751	761	expression	T045	C1171362
27299886	762	767	level	T080	C0441889
27299886	771	775	Sdc1	T116,T123	C1609943
27299886	780	788	compared	T052	C1707455
27299886	797	803	groups	T098	C1257890
27299886	819	831	pre-delivery	T079	C3847846
27299886	832	838	plasma	T031	C0032105
27299886	839	846	soluble	T080	C1948047
27299886	847	851	Sdc1	T116,T123	C1609943
27299886	853	865	Participants	T098	C0679646
27299886	886	907	Magee-Womens Hospital	T073,T093	C0019994
27299886	912	935	uncomplicated pregnancy	T033	C4314562
27299886	937	943	plasma	T031	C0032105
27299886	944	951	soluble	T080	C1948047
27299886	952	956	Sdc1	T116,T123	C1609943
27299886	983	996	1st trimester	T079	C0032979
27299886	1050	1058	compared	T052	C1707455
27299886	1062	1076	post pregnancy	T079	C0086839
27299886	1077	1083	levels	T080	C0441889
27299886	1085	1092	Soluble	T080	C1948047
27299886	1093	1097	Sdc1	T116,T123	C1609943
27299886	1102	1107	lower	T080	C0205251
27299886	1111	1124	mid-pregnancy	T080	C1948047
27299886	1128	1133	women	T098	C0043210
27299886	1154	1166	preeclampsia	T046	C0032914
27299886	1185	1209	gestational hypertension	T047	C0852036
27299886	1211	1219	compared	T052	C1707455
27299886	1223	1231	controls	T096	C0009932
27299886	1246	1251	lower	T080	C0205251
27299886	1255	1269	late pregnancy	T046	C0878751
27299886	1273	1285	preeclampsia	T046	C0032914
27299886	1295	1303	compared	T052	C1707455
27299886	1307	1315	controls	T096	C0009932
27299886	1317	1321	Sdc1	T116,T123	C1609943
27299886	1338	1347	expressed	T045	C1171362
27299886	1351	1370	syncytiotrophoblast	T025	C1515108
27299886	1374	1384	microvilli	T026	C0026049
27299886	1386	1405	Syncytiotrophoblast	T025	C1515108
27299886	1406	1410	Sdc1	T116,T123	C1609943
27299886	1411	1437	immunostaining intensities	T059	C4288189
27299886	1443	1447	mRNA	T114,T123	C0035696
27299886	1459	1478	villous homogenates	T080	C1519984
27299886	1485	1490	lower	T080	C0205251
27299886	1494	1506	preeclampsia	T046	C0032914
27299886	1511	1519	controls	T096	C0009932
27299886	1530	1537	Soluble	T080	C1948047
27299886	1538	1542	Sdc1	T116,T123	C1609943
27299886	1547	1551	Sdc1	T116,T123	C1609943
27299886	1552	1566	immunostaining	T059	C0487602
27299886	1567	1573	scores	T081	C0449820
27299886	1589	1604	associated with	T080	C0332281
27299886	1605	1629	systolic blood pressures	T201	C0871470
27299886	1646	1656	correlated	T080	C1707520
27299886	1662	1668	infant	T100	C0021270
27299886	1669	1681	birth weight	T032	C0005612
27299886	1682	1692	percentile	T081	C1264641
27299886	1694	1701	Soluble	T080	C1948047
27299886	1702	1706	Sdc1	T116,T123	C1609943
27299886	1724	1729	lower	T080	C0205251
27299886	1741	1749	clinical	T080	C0205210
27299886	1750	1758	onset of	T080	C0332162
27299886	1759	1771	preeclampsia	T046	C0032914
27299886	1778	1785	reduced	T080	C0392756
27299886	1786	1796	expression	T045	C1171362
27299886	1800	1804	Sdc1	T116,T123	C1609943
27299886	1812	1821	delivered	T033	C0566687
27299886	1822	1830	placenta	T018	C0032043
27299886	1854	1864	glycocalyx	T026	C0061622
27299886	1880	1892	preeclampsia	T046	C0032914
27299886	1893	1908	pathophysiology	T046	C0277785